Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors

被引:35
作者
Yang, Fang [1 ]
Cao, Lulu [1 ]
Sun, Zijia [1 ]
Jin, Juan [1 ]
Fang, Hehui [1 ]
Zhang, Wenwen [1 ]
Guan, Xiaoxiang [1 ]
机构
[1] Nanjing Univ, Jinling Hosp, Sch Med, Dept Med Oncol, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China
来源
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2016年 / 12卷 / 12期
关键词
breast cancer stem cell; intratumor stemness heterogeneity; prognosis; triple-negative breast cancer; DEHYDROGENASE; 1; EXPRESSION; CLINICOPATHOLOGICAL SIGNIFICANCE; CD44(+)/CD24(-) PHENOTYPE; ALDH1; CD133; POOR-PROGNOSIS; TUMOR-CELLS; MARKERS; IDENTIFICATION; CHEMOTHERAPY;
D O I
10.7150/ijbs.16874
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Triple-negative breast cancer (TNBC) is a tumor subtype with aggressive behavior and poor clinical outcome for lacking effective therapies. Breast cancer stem cells (BCSCs) have been suggested to have tumor-initiating properties, but it remains unclear whether their presence contributes to the increased aggressiveness and poor prognosis of TNBC. Also, the breast cancers display frequent inter-and intra-tumor heterogeneity, which adds the complexity in diagnosis and predicting prognosis. Here we investigated the clinical relevance and prognostic value of the BCSC markers, CD44(+)/CD24(-), aldehyde dehydrogenase family 1 member A1 (ALDH1A1) and CD133 in 88 TNBC cases. We found that a few patients displayed spatial heterogeneity of the BCSC markers in expression, which was defined as intratumor stemness heterogeneity (ITSH) below. There was no significant correlation between any BCSC marker alone or ITSH and progression-free survival (PFS). Interestingly, the combined BCSC phenotype by CD44(+)/CD24(-) and ALDH1A1 was significantly associated with worse PFS (P = 0.009). Further stratification analysis revealed that this combined BCSC phenotype was an independent prognostic factor for PFS in some subgroups. In conclusion, we demonstrated the existence of ITSH in TNBC and found that the ITSH as well as a single BCSC marker was not significantly associated with survival, whereas combing the analysis of BCSC markers could improve prognostic value. Our findings may lead to an improvement of prognostic indicators in TNBC.
引用
收藏
页码:1568 / 1577
页数:10
相关论文
共 50 条
[1]  
Abraham BK, 2005, CLIN CANCER RES, V11, P1154
[2]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[3]   Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer [J].
Alamgeer, Muhammad ;
Ganju, Vinod ;
Kumar, Beena ;
Fox, Jane ;
Hart, Stewart ;
White, Michelle ;
Harris, Marion ;
Stuckey, John ;
Prodanovic, Zdenka ;
Schneider-Kolsky, Michal Elisabeth ;
Watkins, D. Neil .
BREAST CANCER RESEARCH, 2014, 16 (02)
[4]   Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance [J].
Ali, H. Raza ;
Dawson, Sarah-Jane ;
Blows, Fiona M. ;
Provenzano, Elena ;
Pharoah, Paul D. ;
Caldas, Carlos .
BREAST CANCER RESEARCH, 2011, 13 (06)
[5]   CD133 Is a Useful Surrogate Marker for Predicting Chemosensitivity to Neoadjuvant Chemotherapy in Breast Cancer [J].
Aomatsu, Naoki ;
Yashiro, Masakazu ;
Kashiwagi, Shinichiro ;
Takashima, Tsutomu ;
Ishikawa, Tetsuro ;
Ohsawa, Masahiko ;
Wakasa, Kenichi ;
Hirakawa, Kosei .
PLOS ONE, 2012, 7 (09)
[6]   Breast-cancer stem cells-beyond semantics [J].
Badve, Sunil ;
Nakshatri, Harikrishna .
LANCET ONCOLOGY, 2012, 13 (01) :E43-E48
[7]   Strong correlation between N-cadherin and CD133 in breast cancer: role of both markers in metastatic events [J].
Bock, Carolin ;
Kuhn, Christina ;
Ditsch, Nina ;
Krebold, Regina ;
Heublein, Sabine ;
Mayr, Doris ;
Doisneau-Sixou, Sophie ;
Jeschke, Udo .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (11) :1873-1881
[8]   Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer [J].
Brooks, Michael D. ;
Burness, Monika L. ;
Wicha, Max S. .
CELL STEM CELL, 2015, 17 (03) :260-271
[9]   In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness [J].
Brugnoli, Federica ;
Grassilli, Silvia ;
Piazzi, Manuela ;
Palomba, Maria ;
Nika, Ervin ;
Bavelloni, Alberto ;
Capitani, Silvano ;
Bertagnolo, Valeria .
MOLECULAR CANCER, 2013, 12
[10]   Tumor-Endothelial Interaction Links the CD44+/CD24- Phenotype with Poor Prognosis in Early-Stage Breast Cancer [J].
Buess, Martin ;
Rajski, Michal ;
Vogel-Durrer, Brigitte M. L. ;
Herrmann, Richard ;
Rochlitz, Christoph .
NEOPLASIA, 2009, 11 (10) :987-1002